These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 25165162)

  • 41. Distinct Pathogenic Patterns of
    Chen YL; Hsu DW; Hsueh PT; Chen JA; Shih PJ; Lee S; Lin HH; Chen YS
    Am J Trop Med Hyg; 2019 Oct; 101(4):736-745. PubMed ID: 31392941
    [No Abstract]   [Full Text] [Related]  

  • 42. The cluster 1 type VI secretion system is a major virulence determinant in Burkholderia pseudomallei.
    Burtnick MN; Brett PJ; Harding SV; Ngugi SA; Ribot WJ; Chantratita N; Scorpio A; Milne TS; Dean RE; Fritz DL; Peacock SJ; Prior JL; Atkins TP; Deshazer D
    Infect Immun; 2011 Apr; 79(4):1512-25. PubMed ID: 21300775
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A role of Burkholderia pseudomallei flagella as a virulent factor.
    Chuaygud T; Tungpradabkul S; Sirisinha S; Chua KL; Utaisincharoen P
    Trans R Soc Trop Med Hyg; 2008 Dec; 102 Suppl 1():S140-4. PubMed ID: 19121676
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of RelA and SpoT in Burkholderia pseudomallei virulence and immunity.
    Müller CM; Conejero L; Spink N; Wand ME; Bancroft GJ; Titball RW
    Infect Immun; 2012 Sep; 80(9):3247-55. PubMed ID: 22778096
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Burkholderia pseudomallei as an Enteric Pathogen: Identification of Virulence Factors Mediating Gastrointestinal Infection.
    Sanchez-Villamil JI; Tapia D; Borlee GI; Borlee BR; Walker DH; Torres AG
    Infect Immun; 2020 Dec; 89(1):. PubMed ID: 33106293
    [No Abstract]   [Full Text] [Related]  

  • 46. Production and purification of Burkholderia pseudomallei BipD protein.
    Visutthi M; Jitsurong S; Chotigeat W
    Southeast Asian J Trop Med Public Health; 2008 Jan; 39(1):109-14. PubMed ID: 18567449
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A novel FK-506-binding-like protein that lacks peptidyl-prolyl isomerase activity is involved in intracellular infection and in vivo virulence of Burkholderia pseudomallei.
    Norville IH; Breitbach K; Eske-Pogodda K; Harmer NJ; Sarkar-Tyson M; Titball RW; Steinmetz I
    Microbiology (Reading); 2011 Sep; 157(Pt 9):2629-2638. PubMed ID: 21680634
    [TBL] [Abstract][Full Text] [Related]  

  • 48. BALB/c and C57Bl/6 mice infected with virulent Burkholderia pseudomallei provide contrasting animal models for the acute and chronic forms of human melioidosis.
    Leakey AK; Ulett GC; Hirst RG
    Microb Pathog; 1998 May; 24(5):269-75. PubMed ID: 9600859
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Development of novel animal infection models for the study of acute and chronic Burkholderia pseudomallei pulmonary infections.
    van Schaik E; Tom M; DeVinney R; Woods DE
    Microbes Infect; 2008 Oct; 10(12-13):1291-9. PubMed ID: 18707015
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A predicted cation transporter protein, BPSS1228, is involved in intracellular behaviour of Burkholderia pseudomallei in a human lung epithelial cell line (A549).
    Techawiwattanaboon T; Chareonsudjai S
    FEMS Microbiol Lett; 2016 Dec; 363(23):. PubMed ID: 28003338
    [TBL] [Abstract][Full Text] [Related]  

  • 51.
    Jitprasutwit N; Rungruengkitkun A; Lohitthai S; Reamtong O; Indrawattana N; Sookrung N; Sricharunrat T; Sukphopetch P; Chatratita N; Pumirat P
    Microbiol Spectr; 2023 Aug; 11(4):e0132023. PubMed ID: 37409935
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification of Burkholderia pseudomallei genes required for the intracellular life cycle and in vivo virulence.
    Pilatz S; Breitbach K; Hein N; Fehlhaber B; Schulze J; Brenneke B; Eberl L; Steinmetz I
    Infect Immun; 2006 Jun; 74(6):3576-86. PubMed ID: 16714590
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Systematic mutagenesis of genes encoding predicted autotransported proteins of Burkholderia pseudomallei identifies factors mediating virulence in mice, net intracellular replication and a novel protein conferring serum resistance.
    Lazar Adler NR; Stevens MP; Dean RE; Saint RJ; Pankhania D; Prior JL; Atkins TP; Kessler B; Nithichanon A; Lertmemongkolchai G; Galyov EE
    PLoS One; 2015; 10(4):e0121271. PubMed ID: 25830295
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Transcriptome analysis of Burkholderia pseudomallei T6SS identifies Hcp1 as a potential serodiagnostic marker.
    Chieng S; Mohamed R; Nathan S
    Microb Pathog; 2015 Feb; 79():47-56. PubMed ID: 25616255
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Advances and remaining uncertainties in the epidemiology of Burkholderia pseudomallei and melioidosis.
    Currie BJ
    Trans R Soc Trop Med Hyg; 2008 Mar; 102(3):225-7. PubMed ID: 18166205
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Experimental Persistent Infection of BALB/c Mice with Small-Colony Variants of Burkholderia pseudomallei Leads to Concurrent Upregulation of PD-1 on T Cells and Skewed Th1 and Th17 Responses.
    See JX; Samudi C; Saeidi A; Menon N; Choh LC; Vadivelu J; Shankar EM
    PLoS Negl Trop Dis; 2016 Mar; 10(3):e0004503. PubMed ID: 26974441
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Burkholderia pseudomallei virulence: definition, stability and association with clonality.
    Ulett GC; Currie BJ; Clair TW; Mayo M; Ketheesan N; Labrooy J; Gal D; Norton R; Smith CA; Barnes J; Warner J; Hirst RG
    Microbes Infect; 2001 Jul; 3(8):621-31. PubMed ID: 11445448
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A type IV pilin, PilA, Contributes To Adherence of Burkholderia pseudomallei and virulence in vivo.
    Essex-Lopresti AE; Boddey JA; Thomas R; Smith MP; Hartley MG; Atkins T; Brown NF; Tsang CH; Peak IR; Hill J; Beacham IR; Titball RW
    Infect Immun; 2005 Feb; 73(2):1260-4. PubMed ID: 15664977
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Burkholderia pseudomallei pathogenesis in human skin fibroblasts: A Bsa type III secretion system is involved in the invasion, multinucleated giant cell formation, and cellular damage.
    Kaewpan A; Duangurai T; Rungruengkitkun A; Muangkaew W; Kanjanapruthipong T; Jitprasutwit N; Ampawong S; Sukphopetch P; Chantratita N; Pumirat P
    PLoS One; 2022; 17(2):e0261961. PubMed ID: 35113856
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Contribution of gene loss to the pathogenic evolution of Burkholderia pseudomallei and Burkholderia mallei.
    Moore RA; Reckseidler-Zenteno S; Kim H; Nierman W; Yu Y; Tuanyok A; Warawa J; DeShazer D; Woods DE
    Infect Immun; 2004 Jul; 72(7):4172-87. PubMed ID: 15213162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.